Patients hospitalized with community-acquired pneumonia:: a comparative study of outcomes by medical specialty area

被引:16
|
作者
Capelastegui, A
España, PP
Quintana, JM
Gorordo, I
Urquiri, AM
Idoiaga, I
Bilbao, A
机构
[1] Hosp Galdakao, Serv Neumol, Galdakao 48960, Bizkaia, Spain
[2] Hosp Galdakao, Unidad Invest, Galdakao, Bizkaia, Spain
[3] Hosp Galdakao, Serv Urgencias, Galdakao, Bizkaia, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2005年 / 41卷 / 06期
关键词
community-acquired pneumonia; variability; treatment; results;
D O I
10.1157/13075996
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OBJECTIVE: Variability in the management of patients hospitalized with community-acquired pneumonia (CAP) is attributable to many factors. The objective of this study was to determine whether such variability is influenced by the medical specialty area where the patient is treated. PATIENTS AND METHODS: The treatment and outcomes for a random sample of patients with CAP admitted to 4 hospitals over 2 periods (I year starting March 1, 1998, and 1.5 years starting March 1, 2000) were compared by medical specialty department. Multiple linear and logistic regression models were used to analyze differences. RESULTS: Differences were found between departments in the coverage of atypical pathogens (P <.001). The adjusted mean length of stay in hospital varied between 6.8 and 9.1 days (P <.01), and the duration of intravenous treatment varied between 4.6 and 7.3 days (P <.05). Adjusted models showed that mortality in hospital and at 30 days was significantly higher for patients treated in internal medicine departments (odds ratios, 2.1 and 2, respectively) than for those treated in pulmonology departments. CONCLUSIONS: Interdepartmental differences were observed in how patients hospitalized with CAP were treated and in the outcomes achieved. This variation is probably influenced by the differences that were found in the use of antibiotics.
引用
收藏
页码:300 / 306
页数:7
相关论文
共 50 条
  • [1] Diabetes hinders community-acquired pneumonia outcomes in hospitalized patients
    Martins, M.
    Boavida, J. M.
    Raposo, J. F.
    Froes, F.
    Nunes, B.
    Ribeiro, R. T.
    Macedo, M. P.
    Penha-Goncalves, C.
    BMJ OPEN DIABETES RESEARCH & CARE, 2016, 4 (01)
  • [2] A comparative study of meropenem and ceftazidime in the treatment of patients hospitalized with community-acquired pneumonia.
    Berman, SJ
    Sieger, B
    Geckler, RW
    Farkas, SA
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1997, 58 (12): : 903 - 916
  • [3] Effects of statins on clinical outcomes in hospitalized patients with community-acquired pneumonia
    Zeenny, Rony M.
    Mansour, Hanine
    Kabbara, Wissam K.
    Chamoun, Nibal
    Audi, Myriam
    Yared, Yasmina
    Salameh, Pascale
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (08)
  • [4] Effect of empiric regimen on outcomes in hospitalized patients with community-acquired pneumonia
    Brown, PD
    Trowbridge, J
    Artymowicz, R
    Lee, C
    Farber, M
    Kernan, W
    Beaulieu, J
    Goldman, MP
    Lewis, JS
    Ravikrishnan, K
    Lubowski, T
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1110 - 1110
  • [5] Treatment of hospitalized patients with community-acquired pneumonia
    Leenders, ACAP
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (01) : 109 - 110
  • [6] PROGNOSIS OF PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA
    FINE, MJ
    ORLOFF, JJ
    ARISUMI, D
    FANG, G
    ARENA, VC
    HANUSA, BH
    YU, VL
    SINGER, DE
    KAPOOR, WN
    AMERICAN JOURNAL OF MEDICINE, 1990, 88 (5N): : N1 - N8
  • [7] Prognosis of hospitalized patients with community-acquired pneumonia
    Akyil, F. Tokgoz
    Yalcinsoy, M.
    Hazar, A.
    Cilli, A.
    Celenk, B.
    Kilic, O.
    Sayiner, A.
    Kokturk, N.
    Coskun, A. Sakar
    Filiz, A.
    Edis, E. Cakir
    PULMONOLOGY, 2018, 24 (03): : 164 - 169
  • [8] Eosinopenia in Hospitalized Patients With Community-acquired Pneumonia
    Farah, W. H.
    Odeyemi, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [9] Corticosteroids for Hospitalized Patients with Community-Acquired Pneumonia
    Cayley, William E., Jr.
    AMERICAN FAMILY PHYSICIAN, 2020, 102 (05) : 272 - 273
  • [10] Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia
    Burgess, DS
    Lewis, JS
    CLINICAL THERAPEUTICS, 2000, 22 (07) : 872 - 878